Consensus MYT Netherlands Parent B.V.

Equities

MYTE

US55406W1036

Real-time Estimate Cboe BZX 09:43:29 2024-03-28 am EDT 5-day change 1st Jan Change
3.28 USD +4.13% Intraday chart for MYT Netherlands Parent B.V. -17.32% -1.25%

Evolution of the average Target Price on MYT Netherlands Parent B.V.

Price target over the last 5 years

History of analyst recommendation changes

0d2b0bbac31db4ef74e05168.txoABsevMtPyH2cy484_GPLm3uD-6ahWjPTmyNAZrkU.zXlKUaHMapK8fDdcmvp7f6qvnKKRuOUx7a2_l51t1ATZIjJhsvVelZV5Uw~95a12dfbbaf9cfb6ab7f88789e86319b
UBS Trims MYT Netherlands Parent BV ADS Price Target to $4.75 From $5, Maintains Buy Rating MT
UBS Trims MYT Netherlands Price Target to $5 From $5.20, Maintains Buy Rating MT
BofA Securities Adjusts MYT Netherlands Price Target to $6.50 From $8, Maintains Buy Rating MT
UBS Adjusts MYT Netherlands Price Target to $5.20 From $4.60, Maintains Buy Rating MT
BofA Securities Adjusts Price Target on MYT Netherlands Parent to $8 From $14, Maintains Buy Rating MT
UBS Adjusts MYT Netherlands Parent BV ADS Price Target to $8 From $10, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on MYT Netherlands to $6 From $9, Maintains Equalweight Rating MT
Societe Generale Downgrades MYT Netherlands Parent to Hold From Buy, Price Target is $7 MT
JPMorgan Downgrades Mytheresa ADS to Neutral From Overweight, Adjusts Price Target to $7 From $9 MT
UBS Adjusts MYT Netherlands' Price Target to $10 From $14, Maintains Buy Rating MT
TD Cowen Downgrades MYT Netherlands to Market Perform From Outperform, Adjusts Price Target to $7 From $13 MT
Morgan Stanley Adjusts Price Target on MYT Netherlands to $9 From $10, Maintains Equal-Weight Rating MT
UBS Adjusts MYT Netherlands Parent Price Target to $14 From $16, Maintains Buy Rating MT
UBS Adjusts MYT Netherlands Parent BV ADS Price Target to $16 From $14, Maintains Buy Rating MT
Credit Suisse Trims MYT Netherlands Parent's Price Target to $15 from $16 After Fiscal Q4 Results, Maintains Outperform Rating MT
JPMorgan Raises MYT Netherlands Parent's Price Target to $18 From $15, Maintains Overweight Rating MT
Morgan Stanley Lowers MYT Netherlands Parent's Price Target to $12 From $14, Maintains Equalweight Rating MT
Cowen Adjusts Price Target on MYT Netherlands Parent BV to $17 From $22, Keeps Outperform Rating MT
UBS Adjusts MYT Netherlands Price Target to $14 From $15, Maintains Buy Rating MT
UBS Adjusts MYT Netherlands Parent BV Price Target to $15 From $19, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on Mytheresa to $15 From $23, Reiterates Overweight Rating MT
Credit Suisse Lowers MYT Netherlands Parent's Price Target to $16 from $18, Keeps Outperform Rating MT
Morgan Stanley Downgrades MYT Netherlands Parent to Equalweight from Overweight, Adjusts Price Target to $14 from $39 MT
UBS Upgrades MYT Netherlands Parent to Buy From Neutral, Sets $19 Price Target MT
JPMorgan Adjusts Price Target on MYT Netherlands Parent to $23 From $34, Reiterates Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.911 EUR
Average target price
3.633 EUR
Spread / Average Target
+24.80%
High Price Target
4.654 EUR
Spread / Highest target
+59.86%
Low Price Target
2.785 EUR
Spread / Lowest Target
-4.34%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MYT Netherlands Parent B.V.

UBS
BofA Securities
Societe Generale
Morgan Stanley
JPMorgan Chase
TD Cowen
Cowen
Credit Suisse
J.P. Morgan Chase
Jefferies & Co.
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
  1. Stock
  2. Equities
  3. Stock MYT Netherlands Parent B.V. - Nyse
  4. Consensus MYT Netherlands Parent B.V.